Bank Of New York Mellon Corp Mirum Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$17.59 - $23.83 $1.15 Million - $1.56 Million	65,512 New	65,512 $1.28 Million
Q3 2022 Nov 14, 2022	SELL	$19.98 - $29.44 $257,182 - $378,951	-12,872 Reduced 17.48%	60,775 $1.28 Million
Q2 2022 Aug 15, 2022	BUY	$18.42 - $27.5 $926,139 - $1.38 Million	50,279 Added 215.16%	73,647 $1.43 Million
Q1 2022 May 11, 2022	SELL	$15.5 - $23.93 $12,803 - $19,766	-826 Reduced 3.41%	23,368 $515,000
Q4 2021 Feb 11, 2022	BUY	$13.05 - $19.35 $4,567 - $6,772	350 Added 1.47%	24,194 $385,000
Q3 2021 Nov 12, 2021	BUY	$13.95 - $20.18 $5,803 - $8,394	416 Added 1.78%	23,844 $475,000
Q2 2021 Aug 11, 2021	SELL	$15.84 - $20.6 $55,107 - $71,667	-3,479 Reduced 12.93%	23,428 $405,000
Q1 2021 May 13, 2021	SELL	$16.29 - $21.92 $10,800 - $14,532	-663 Reduced 2.4%	26,907 $533,000
Q4 2020 Feb 09, 2021	BUY	$15.75 - $25.45 $128,236 - $207,213	8,142 Added 41.91%	27,570 $481,000
Q3 2020 Nov 12, 2020	SELL	$18.4 - $26.59 $10,580 - $15,289	-575 Reduced 2.87%	19,428 $374,000
Q2 2020 Aug 12, 2020	BUY	$11.51 - $20.97 $33,091 - $60,288	2,875 Added 16.79%	20,003 $389,000
Q1 2020 May 06, 2020	BUY	$9.38 - $23.79 $52,715 - $133,699	5,620 Added 48.84%	17,128 $239,000
Q4 2019 Feb 14, 2020	BUY	$6.84 - $25.9 $78,714 - $298,057	11,508 New	11,508 $282,000

197

54.3M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.92B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.